| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.055 | 0.2 |